Fill out this short form to download the white paper.
Download our white paper, with new research from ixlayer and Ipsos, exploring how consumer expectations for a digital ecosystem have become crucial for biopharmaceutical companies aiming to enhance patient engagement.
Only 16% of survey respondents strongly agreed with the statement, “Pharma companies are patient centric and prioritize the needs and preferences of the patient.”¹
of survey respondents strongly or somewhat agreed that pharmaceutical companies should provide resources to patients to help them get the care and medicines they need.²
of survey respondents said they would have a much more improved or somewhat more improved perception of a pharma company that offers patient-centric digital health solutions.³
2 ixInsights 2025 / Ipsos Patient research, Top 2 Box, Base All n=414 individuals with one of the following conditions: respiratory conditions, asthma, COPD, type 2 diabetes, heart disease, dermatologic conditions, psoriasis, or atopic dermatitis. – On a scale from 1 to 5, where 1 is strongly disagree and 5 is strongly agree, please rate how much you agree or disagree with the following statements: “Pharmaceutical companies should provide resources to patients to help them get the care and medicines they need.”
IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108
IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038
